8-K: Supernus Pharmaceuticals Announces Retirement of Senior VP of Regulatory Affairs and Successor Appointment
Executive Change Announcement
Supernus Pharmaceuticals reports the retirement of Tami T. Martin, Senior Vice President of Regulatory Affairs, effective May 3, 2024, and the appointment of Roman Bradel as her successor in March 2024.
Summary
- Supernus Pharmaceuticals announced the retirement of Tami T. Martin, the Senior Vice President of Regulatory Affairs, effective May 3, 2024.
- Roman Bradel, Ph.D., is expected to join the company in March 2024 as the new Vice President of Regulatory Affairs.
- Bradel will report to Frank Mottola, the Senior Vice President of Quality, GMP Operations and IT.
Sentiment
Score: 7
Explanation: The announcement is neutral, detailing a planned executive transition. The sentiment is slightly positive due to the smooth succession plan.
Industry Context
Executive transitions are common in the pharmaceutical industry, and this change at Supernus is part of the normal course of business.
Comparison to Industry Standards
- Executive transitions are a regular occurrence in the pharmaceutical industry, with companies often announcing retirements and new appointments.
- The appointment of a new VP of Regulatory Affairs is a key step for Supernus to maintain its regulatory compliance and product development efforts.
- Comparable companies also experience similar executive changes, and the smooth transition is crucial for continued operations.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Senior Vice President, Regulatory Affairs | Tami T. Martin | Roman Bradel | May 3, 2024 | Retirement |
Stakeholder Impact
- Shareholders may view the smooth transition as a positive sign of management continuity.
- Employees in the regulatory affairs department will experience a change in leadership.
- The transition is not expected to impact customers or suppliers.
Next Steps
- Roman Bradel will join the company in March 2024.
- Tami T. Martin will retire on May 3, 2024.
Key Dates
| Date | Description |
|---|---|
| February 14, 2024 | Tami T. Martin notified Supernus of her retirement. |
| March 2024 | Roman Bradel is expected to join Supernus as Vice President of Regulatory Affairs. |
| May 3, 2024 | Tami T. Martin's retirement from Supernus becomes effective. |
Keywords
Regulatory Affairs, Pharmaceuticals, Executive Change, Retirement, Appointment, Supernus
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.